Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, Chief Medical Officer acquired 196,200 shares (grant or award)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Material agreement · Agreement ended · Exit or restructuring costs
  6. SC 13G Stake Amended Statement of Ownership
  7. 8-K Event Executive or director change
  8. CT ORDER Other Confidential Order
  9. 8-K Event Delisting notice
  10. 8-K Event Exit or restructuring costs
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. CT ORDER Other Confidential Order
  14. 4 Open-market sale SVP, Chief Medical Officer sold 1,147 shares at $0.36 ($416)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 8-K Event Material agreement
  18. SC 13G Stake Amended Statement of Ownership
  19. 8-K Event Material agreement · Agreement ended
  20. 4 Grant or award SVP, CFO and Treasurer acquired 200,000 shares (grant or award)

Page 14 of 45 · 886 filings